China Insurers Launch Standard Clauses and Drug List for Commercial Health Cover

Standardized clauses and a recommended drug list shift commercial health underwriting from bespoke policy wording toward a shared industry reference, which matters most for the insurers now writing these products and for how city-customised plans are structured. The drug list is the lever to watch: it defines what commercial cover is expected to include, so adoption across carriers, rather than the publication itself, is the open question. Whether the recommended list becomes a de facto benchmark for product design is the next signal.